Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Operating activities:
Net income	$ 40.9	$ 15.7
Adjustment to reconcile net income to cash (used for) provided by operating activities:
Depreciation and amortization	77.7	76.4
Amortization of deferred financing costs and original issue discount	2.4	2.2
Deferred income taxes	(2.7)	(18.3)
Realized and unrealized foreign exchange losses, net	2.4	8.6
Stock-based compensation	5.3	3.6
Interest income on swaps designated as net investment hedges	(6.2)	(3.5)
Other non-cash, net	(1.6)	1.4
Changes in operating assets and liabilities:
Trade accounts and notes receivable	(86.2)	(52.6)
Inventories	(91.5)	(36.2)
Prepaid expenses and other assets	(32.9)	(18.0)
Accounts payable	120.4	33.4
Other accrued liabilities	(66.7)	30.7
Other liabilities	(5.2)	(3.8)
Cash (used for) provided by operating activities	(43.9)	39.6
Investing activities:
Purchase of property, plant and equipment	(42.5)	(31.8)
Interest proceeds on swaps designated as net investment hedges	6.2	3.5
Settlement proceeds on swaps designated as net investment hedges	25.0	0.0
Other investing activities, net	1.0	0.5
Cash used for investing activities	(10.3)	(27.8)
Financing activities:
Payments on short-term borrowings	(24.1)	(20.0)
Payments on long-term borrowings	(6.8)	(6.7)
Financing-related costs	0.0	(1.5)
Purchases of common stock	(175.1)	(63.7)
Net cash flows associated with stock-based awards	(1.9)
Net cash flows associated with stock-based awards		0.1
Other financing activities, net	(0.2)	(0.7)
Cash used for financing activities	(208.1)	(92.5)
Decrease in cash	(262.3)	(80.7)
Effect of exchange rate changes on cash	(2.1)	(13.5)
Cash at beginning of period	851.2	1,364.0	$ 1,364.0
Cash at end of period	586.8	1,269.8	851.2
Cash at end of period reconciliation:
Cash and cash equivalents	576.2	1,266.9	840.6
Restricted cash	10.6	2.9	10.6
Cash at end of period	$ 586.8	$ 1,269.8	$ 851.2